查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1494770

到 2030 年神经修復和再生市场预测：按产品类型、病理类型、应用、最终用户和地区进行的全球分析

Nerve Repair and Regeneration Market Forecasts to 2030 - Global Analysis By Product Type (Biomaterials, Neuromodulation Devices and Other Product Types), Condition Type, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据Stratistics MRC预测，2024年全球神经修復与再生市场规模将达103亿美元，预计2030年将达到253亿美元，预测期内复合年增长率为16.1%。

神经修復和再生是指将体内受损或受伤的神经恢復到功能状态的自然或辅助过程。这涉及受损神经组织的修復和神经纤维的再生，从而恢復感觉和运动功能。这些过程在某种程度上在体内自然发生，但也可以透过手术、神经移植和再生疗法等医疗介入来促进。最终目标是恢復神经功能并加速神经损伤或残疾的恢復。

据阿兹海默症协会称，到2022年，65岁以上的美国人将有650万人患有阿兹海默症。

老年人口增加

该市场的成长很大程度上得益于老年人口的增加。随着医疗保健的进步，越来越多的老年人正在寻求神经相关疾病的治疗。这种人口结构的变化正在推动对神经修復和再生创新解决方案的需求。由于老年人面临神经病变和损伤等挑战，迫切需要恢復功能和改善生活品质的治疗方法。这一趋势凸显了市场扩张和创新的潜力。

目前的治疗方法效果有限

由于目前治疗方法的有效性有限，市场面临重大挑战。儘管取得了进展，但许多现有方法仍难以完全恢復神经功能，尤其是在复杂的情况下。这项限制凸显了对创新解决方案的迫切需求，这些解决方案可以改善再生结果并满足不同的患者需求。开拓高度成功且广泛适用的治疗方法仍然是克服市场面临的障碍的重要目标。

技术进步

神经修復和再生技术的最新趋势包括开发生物工程神经移植物，例如神经导管和支架，以促进神经再生。此外，干细胞疗法、基因疗法和神经组织工程等创新方法已显示出增强神经修復效果的潜力。先进的影像技术和神经刺激技术也有助于绘製神经途径并促进神经再生。

昂贵的程序费用

这个市场的治疗成本很高，对寻求治疗的患者造成了巨大的经济障碍。它们通常花费数千甚至数万美元，并且易用性是一个主要问题。这些高昂的费用延伸到外科手术、专业诊断和术后护理，加重了个人和医疗保健系统的经济负担。应对这项挑战对于确保公平获得基本的神经修復和再生治疗至关重要。

COVID-19 的影响：

COVID-19 大流行严重影响了神经修復和再生市场，导致医疗服务中断和择期手术延迟。患者就诊和外科手术的减少导致市场成长下降。供应链中断也阻碍了医疗设备和治疗的取得。然而，随着医疗保健服务逐渐恢復以及对神经损伤的认识增强，市场有望復苏。远端医疗和远端患者监护的创新可能会重塑市场动态，并推动神经修復和再生技术的未来成长。

预计生医材料领域在预测期内将是最大的。

预计生物材料在预测期内将占据最大份额。这些生医材料，包括水凝胶、支架和导管，为修復受损神经和促进再生提供了有前景的解决方案。神经损伤发生率的增加和微创手术技术的日益采用进一步推动了市场扩张。此外，正在进行的研究工作和合作旨在提高这些生物材料的有效性和可及性，并推动市场持续成长。

医院和诊所领域预计在预测期内复合年增长率最高

预计医院和诊所产业在预测期内将经历最高的复合年增长率。这些设施配备了先进的技术，并配备了专注于恢復神经功能和改善患者生活品质的专业医疗专业人员。从神经移植到神经刺激疗法，这些中心根据个人需求提供全面的服务，推动神经病学的进步，并为神经损伤和病症患者带来希望。

比最大的地区

由于神经损伤和疾病的盛行率不断增加、技术进步以及对创新治疗方案的需求不断增长，预计北美将在预测期内占据最大的市场占有率。成熟的医疗基础设施、支持性报销政策和人口老化加剧等因素正在促进市场扩张。主要参与者正专注于开发新治疗方法和扩大产品系列，进一步推动市场成长。

复合年增长率最高的地区：

由于多种因素，亚太地区将在预测期内经历最高的复合年增长率，包括神经损伤发生率的增加、老年人口的增加、神经修復治疗意识的提高以及医疗基础设施和技术的进步预计将得到维持。此外，政府和私人机构对研发活动的投资增加也刺激了该地区神经修復和再生技术的创新。

提供免费客製化：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究资讯来源
    • 主要研究资讯来源
    • 二次研究资讯来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19 的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球神经修復与再生市场：依产品类型

  • 生物材料
    • 神经导管
    • 神经保护剂
    • 神经绷带
    • 神经连接器
  • 神经调节装置
    • 内神经刺激设备
      • 脊髓刺激设备
      • 深层脑部刺激器
      • 荐骨神经刺激器
      • 迷走神经刺激设备
    • 外部神经刺激设备
      • 经皮神经电刺激 (TENS)
      • 经颅磁刺激（TMS）
      • 呼吸电刺激设备
  • 其他产品类型

第六章全球神经修復与再生市场：依疾病类型

  • 外伤性神经损伤
  • 神经退化性疾病
  • 神经压迫症候群
  • 週边神经病变
  • 其他疾病类型

第七章全球神经修復与再生市场：依应用分类

  • 神经移植
    • 自体移植
    • 同种异体移植
    • 异种移植
  • 干细胞疗法
    • 间质干细胞（MSC）
    • 造血干细胞（HSC）
    • 神经干细胞（NSC）
  • 直接神经修復
    • 神经外膜修復
    • 神经周围修復
    • 组束修復
  • 其他用途

第八章全球神经修復与再生市场：依最终用户分类

  • 医院和诊所
  • 日间手术中心 (ASC)
  • 研究实验室和学术机构
  • 其他最终用户

第九章全球神经修復与再生市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第10章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十一章 公司概况

  • Medtronic, Plc.
  • Synovis Micro Companies Alliance
  • Axogen Corporation
  • Checkpoint Surgical
  • Synapse Biomedical Inc.
  • Polyganics
  • Boston scientific inc
  • Nuvectra Corporation
  • Abbott Laboratories
  • OrthoMed, Inc
  • NeuroSigma, Inc.
  • Stryker Corporation
  • Allergan plc
  • Baxter International Inc.
  • Collagen Matrix, Inc.
  • Integra LifeSciences Holdings Corporation
Product Code: SMRC26285

According to Stratistics MRC, the Global Nerve Repair and Regeneration Market is accounted for $10.3 billion in 2024 and is expected to reach $25.3 billion by 2030 growing at a CAGR of 16.1% during the forecast period. Nerve repair and regeneration refer to the natural or assisted processes by which damaged or injured nerves in the body are restored to their functional state. This involves the repair of damaged nerve tissue and the regeneration of nerve fibers, allowing for the restoration of sensory and motor functions. These processes can occur spontaneously to some extent in the body, but they can also be facilitated through medical interventions such as surgery, nerve grafting, or the use of regenerative therapies. The ultimate goal is to restore nerve function and facilitate recovery from nerve injuries or disorders.

According to the Alzheimer's Association, in 2022, 6.5 million people aged 65 or more in America were suffering from Alzheimer's disease.

Market Dynamics:

Driver:

Growing geriatric population

The market is experiencing significant growth, largely due to the increasing geriatric population. With advancements in healthcare, more elderly individuals are seeking treatments for nerve-related conditions. This demographic shift has fueled demand for innovative solutions catering to nerve repair and regeneration. As older adults face challenges such as neuropathy and nerve injuries, there's a pressing need for therapies that can restore function and improve quality of life. This trend underscores the market's potential for expansion and innovation.

Restraint:

Limited efficacy of current treatments

The market faces significant challenges due to the limited efficacy of current treatments. Despite advancements, many existing approaches struggle to fully restore nerve function, especially in complex cases. This limitation underscores the pressing need for innovative solutions that can enhance regeneration outcomes and address diverse patient needs. Developing therapies with higher success rates and broader applicability remains a critical goal in overcoming the hurdles faced by the market.

Opportunity:

Technological advancements

Recent advancements in nerve repair and regeneration technology include the development of bioengineered nerve grafts, such as nerve conduits and scaffolds, to promote nerve regeneration. Additionally, innovative approaches like stem cell therapy, gene therapy, and nerve tissue engineering have shown promise in enhancing nerve repair outcomes. Advanced imaging techniques and neurostimulation methods also aid in mapping nerve pathways and facilitating nerve regeneration.

Threat:

High cost of procedures

The market is marked by steep procedure costs, posing significant financial barriers for patients seeking treatment. With expenses often ranging in the thousands, if not tens of thousands, of dollars, accessibility becomes a major concern. These high costs encompass surgical procedures, specialized diagnostics, and post-operative care, amplifying the financial strain on individuals and healthcare systems alike. Addressing this challenge is crucial for ensuring equitable access to essential nerve repair and regeneration therapies.

Covid-19 Impact:

The COVID-19 pandemic significantly affected the Nerve Repair and Regeneration market, causing disruptions in healthcare services and delaying elective procedures. Reduced patient visits and surgical interventions led to a decline in market growth. Supply chain disruptions also hampered the availability of medical devices and treatments. However, with the gradual recovery of healthcare services and increased awareness of nerve injuries, the market is expected to rebound. Innovations in telemedicine and remote patient monitoring might reshape the market dynamics, driving future growth in nerve repair and regeneration technologies.

The biomaterials segment is expected to be the largest during the forecast period

The biomaterials is expected to be the largest during the forecast period. These biomaterials include hydrogels, scaffolds, and conduits, offer promising solutions for repairing damaged nerves and promoting regeneration. The market's expansion is further propelled by rising incidences of nerve injuries, coupled with the increasing adoption of minimally invasive surgical techniques. Additionally, ongoing research efforts and collaborations aim to enhance the efficacy and accessibility of these biomaterials, fostering continued market growth.

The hospitals and clinics segment is expected to have the highest CAGR during the forecast period

The hospitals and clinics segment is expected to have the highest CAGR during the forecast period. These facilities are equipped with advanced technologies and staffed by expert medical professionals who focus on restoring nerve function and improving patients' quality of life. From nerve grafting to nerve stimulation therapies, these centers offer comprehensive services tailored to individual needs, driving advancements in neurological medicine and fostering hope for those with nerve injuries or conditions.

Region with largest share:

North America is projected to hold the largest market share during the forecast period driven by increasing prevalence of nerve injuries and disorders, technological advancements, and rising demand for innovative treatment options. Factors such as a well-established healthcare infrastructure, supportive reimbursement policies, and a growing aging population contribute to market expansion. Key players are focusing on developing novel therapies and expanding their product portfolios, further fueling market growth.

Region with highest CAGR:

Asia Pacific is projected to hold the highest CAGR over the forecast period due to several factors such as increasing incidences of nerve injuries, growing geriatric population, rising awareness about nerve repair treatments, and advancements in healthcare infrastructure and technologies. Additionally, the increasing investments in research and development activities by both government and private organizations are fueling innovation in nerve repair and regeneration technologies in the region.

Key players in the market

Some of the key players in Nerve Repair and Regeneration market include Medtronic, Plc., Synovis Micro Companies Alliance, Axogen Corporation, Checkpoint Surgical, Synapse Biomedical Inc., Polyganics, Boston scientific inc, Nuvectra Corporation, Abbott Laboratories, OrthoMed, Inc NeuroSigma, Inc., Stryker Corporation, Allergan plc, Baxter International Inc., Collagen Matrix, Inc. and Integra LifeSciences Holdings Corporation

Key Developments:

In March 2024, Medtronic announced the launch of the new UNiD(TM) ePRO service in the United States. This solution will change the way patient outcomes are collected for spine surgeons, reducing the burden on clinic staff and patients. Medtronic has partnered with OBERD, a leading practice intelligence data collection company, to provide spine surgeons with an electronic Patient Reported Outcomes (ePRO) system.

In November 2023, Medtronic launched a new frontier in treating high blood pressure. The U.S. Food and Drug Administration (FDA) today approved the Medtronic Symplicity Spyral(TM) renal denervation system for use in the United States. The system, which carries the FDA's Breakthrough Device designation, uses radio frequency to disrupt overactive nerves in the kidneys and help lower blood pressure.

Product Types Covered:

  • Biomaterials
  • Neuromodulation Devices
  • Other Product Types

Condition Types Covered:

  • Traumatic Nerve Injuries
  • Neurodegenerative Diseases
  • Nerve Compression Syndromes
  • Peripheral Neuropathies
  • Other Condition Types

Applications Covered:

  • Nerve Grafting
  • Stem Cell Therapy
  • Direct Nerve Repair
  • Other Applications

End Users Covered:

  • Hospitals and Clinics
  • Ambulatory Surgical Centers (ASCs)
  • Research Laboratories and Academic Institutes
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Nerve Repair and Regeneration Market, By Product Type

  • 5.1 Introduction
  • 5.2 Biomaterials
    • 5.2.1 Nerve Conduits
    • 5.2.2 Nerve Protectors
    • 5.2.3 Nerve Wraps
    • 5.2.4 Nerve Connectors
  • 5.3 Neuromodulation Devices
    • 5.3.1 Internal Neurostimulation Devices
      • 5.3.1.1 Spinal Cord Stimulators
      • 5.3.1.2 Deep Brain Stimulators
      • 5.3.1.3 Sacral Nerve Stimulators
      • 5.3.1.4 Vagus Nerve Stimulators
    • 5.3.2 External Neurostimulation Devices
      • 5.3.2.1 Transcutaneous Electrical Nerve Stimulation (TENS)
      • 5.3.2.2 Transcranial Magnetic Stimulation (TMS)
      • 5.3.2.3 Respiratory Electrical Stimulation Devices
  • 5.4 Other Product Types

6 Global Nerve Repair and Regeneration Market, By Condition Type

  • 6.1 Introduction
  • 6.2 Traumatic Nerve Injuries
  • 6.3 Neurodegenerative Diseases
  • 6.4 Nerve Compression Syndromes
  • 6.5 Peripheral Neuropathies
  • 6.6 Other Condition Types

7 Global Nerve Repair and Regeneration Market, By Application

  • 7.1 Introduction
  • 7.2 Nerve Grafting
    • 7.2.1 Autografts
    • 7.2.2 Allografts
    • 7.2.3 Xenografts
  • 7.3 Stem Cell Therapy
    • 7.3.1 Mesenchymal Stem Cells (MSCs)
    • 7.3.2 Hematopoietic Stem Cells (HSCs)
    • 7.3.3 Neural Stem Cells (NSCs)
  • 7.4 Direct Nerve Repair
    • 7.4.1 Epineural Repair
    • 7.4.2 Perineural Repair
    • 7.4.3 Group Fascicular Repair
  • 7.5 Other Applications

8 Global Nerve Repair and Regeneration Market, By End User

  • 8.1 Introduction
  • 8.2 Hospitals and Clinics
  • 8.3 Ambulatory Surgical Centers (ASCs)
  • 8.4 Research Laboratories and Academic Institutes
  • 8.5 Other End Users

9 Global Nerve Repair and Regeneration Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Medtronic, Plc.
  • 11.2 Synovis Micro Companies Alliance
  • 11.3 Axogen Corporation
  • 11.4 Checkpoint Surgical
  • 11.5 Synapse Biomedical Inc.
  • 11.6 Polyganics
  • 11.7 Boston scientific inc
  • 11.8 Nuvectra Corporation
  • 11.9 Abbott Laboratories
  • 11.10 OrthoMed, Inc
  • 11.11 NeuroSigma, Inc.
  • 11.12 Stryker Corporation
  • 11.13 Allergan plc
  • 11.14 Baxter International Inc.
  • 11.15 Collagen Matrix, Inc.
  • 11.16 Integra LifeSciences Holdings Corporation

List of Tables

  • Table 1 Global Nerve Repair and Regeneration Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Nerve Repair and Regeneration Market Outlook, By Product Type (2022-2030) ($MN)
  • Table 3 Global Nerve Repair and Regeneration Market Outlook, By Biomaterials (2022-2030) ($MN)
  • Table 4 Global Nerve Repair and Regeneration Market Outlook, By Nerve Conduits (2022-2030) ($MN)
  • Table 5 Global Nerve Repair and Regeneration Market Outlook, By Nerve Protectors (2022-2030) ($MN)
  • Table 6 Global Nerve Repair and Regeneration Market Outlook, By Nerve Wraps (2022-2030) ($MN)
  • Table 7 Global Nerve Repair and Regeneration Market Outlook, By Nerve Connectors (2022-2030) ($MN)
  • Table 8 Global Nerve Repair and Regeneration Market Outlook, By Neuromodulation Devices (2022-2030) ($MN)
  • Table 9 Global Nerve Repair and Regeneration Market Outlook, By Internal Neurostimulation Devices (2022-2030) ($MN)
  • Table 10 Global Nerve Repair and Regeneration Market Outlook, By Spinal Cord Stimulators (2022-2030) ($MN)
  • Table 11 Global Nerve Repair and Regeneration Market Outlook, By Deep Brain Stimulators (2022-2030) ($MN)
  • Table 12 Global Nerve Repair and Regeneration Market Outlook, By Sacral Nerve Stimulators (2022-2030) ($MN)
  • Table 13 Global Nerve Repair and Regeneration Market Outlook, By Vagus Nerve Stimulators (2022-2030) ($MN)
  • Table 14 Global Nerve Repair and Regeneration Market Outlook, By External Neurostimulation Devices (2022-2030) ($MN)
  • Table 15 Global Nerve Repair and Regeneration Market Outlook, By Transcutaneous Electrical Nerve Stimulation (TENS) (2022-2030) ($MN)
  • Table 16 Global Nerve Repair and Regeneration Market Outlook, By Transcranial Magnetic Stimulation (TMS) (2022-2030) ($MN)
  • Table 17 Global Nerve Repair and Regeneration Market Outlook, By Respiratory Electrical Stimulation Devices (2022-2030) ($MN)
  • Table 18 Global Nerve Repair and Regeneration Market Outlook, By Other Product Types (2022-2030) ($MN)
  • Table 19 Global Nerve Repair and Regeneration Market Outlook, By Condition Type (2022-2030) ($MN)
  • Table 20 Global Nerve Repair and Regeneration Market Outlook, By Traumatic Nerve Injuries (2022-2030) ($MN)
  • Table 21 Global Nerve Repair and Regeneration Market Outlook, By Neurodegenerative Diseases (2022-2030) ($MN)
  • Table 22 Global Nerve Repair and Regeneration Market Outlook, By Nerve Compression Syndromes (2022-2030) ($MN)
  • Table 23 Global Nerve Repair and Regeneration Market Outlook, By Peripheral Neuropathies (2022-2030) ($MN)
  • Table 24 Global Nerve Repair and Regeneration Market Outlook, By Other Condition Types (2022-2030) ($MN)
  • Table 25 Global Nerve Repair and Regeneration Market Outlook, By Application (2022-2030) ($MN)
  • Table 26 Global Nerve Repair and Regeneration Market Outlook, By Nerve Grafting (2022-2030) ($MN)
  • Table 27 Global Nerve Repair and Regeneration Market Outlook, By Autografts (2022-2030) ($MN)
  • Table 28 Global Nerve Repair and Regeneration Market Outlook, By Allografts (2022-2030) ($MN)
  • Table 29 Global Nerve Repair and Regeneration Market Outlook, By Xenografts (2022-2030) ($MN)
  • Table 30 Global Nerve Repair and Regeneration Market Outlook, By Stem Cell Therapy (2022-2030) ($MN)
  • Table 31 Global Nerve Repair and Regeneration Market Outlook, By Mesenchymal Stem Cells (MSCs) (2022-2030) ($MN)
  • Table 32 Global Nerve Repair and Regeneration Market Outlook, By Hematopoietic Stem Cells (HSCs) (2022-2030) ($MN)
  • Table 33 Global Nerve Repair and Regeneration Market Outlook, By Neural Stem Cells (NSCs) (2022-2030) ($MN)
  • Table 34 Global Nerve Repair and Regeneration Market Outlook, By Direct Nerve Repair (2022-2030) ($MN)
  • Table 35 Global Nerve Repair and Regeneration Market Outlook, By Epineural Repair (2022-2030) ($MN)
  • Table 36 Global Nerve Repair and Regeneration Market Outlook, By Perineural Repair (2022-2030) ($MN)
  • Table 37 Global Nerve Repair and Regeneration Market Outlook, By Group Fascicular Repair (2022-2030) ($MN)
  • Table 38 Global Nerve Repair and Regeneration Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 39 Global Nerve Repair and Regeneration Market Outlook, By End User (2022-2030) ($MN)
  • Table 40 Global Nerve Repair and Regeneration Market Outlook, By Hospitals and Clinics (2022-2030) ($MN)
  • Table 41 Global Nerve Repair and Regeneration Market Outlook, By Ambulatory Surgical Centers (ASCs) (2022-2030) ($MN)
  • Table 42 Global Nerve Repair and Regeneration Market Outlook, By Research Laboratories and Academic Institutes (2022-2030) ($MN)
  • Table 43 Global Nerve Repair and Regeneration Market Outlook, By Other End Users (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.